Wellness and Longevity Medicine
Hearing Health and Healthy Aging: What the Evidence Shows
Hearing loss can quietly increase listening effort and make conversation, work, and social connection harder. A major randomized trial found no cognitive benefit across all participants, but suggested a meaningful effect among older adults at higher risk of cognitive decline. Here is how to interpret the evidence without turning hearing aids into a dementia-prevention promise.

Hearing Is More Than a Volume Setting
Healthy aging is often discussed in terms of blood pressure, movement, nutrition, sleep, and memory. Hearing deserves a place in that conversation, too.
Age-related hearing loss usually develops gradually and in both ears. That makes it easy to miss. A person may hear that someone is talking but struggle to distinguish the words, especially in a restaurant, meeting, or other noisy setting. They may turn up the television, ask people to repeat themselves, or feel unusually tired after a conversation.
These changes are not merely inconvenient. Hearing supports communication, safety, independence, and participation in daily life. The National Institute on Deafness and Other Communication Disorders estimates that about one in three U.S. adults ages 65 to 74 has hearing loss, as do nearly half of adults older than 75.
Hearing loss has also been associated with social isolation, falls, cognitive decline, and other adverse outcomes. Association does not establish that hearing loss directly causes these problems. Age, vascular disease, access to care, and other factors may influence both hearing and overall health. Still, hearing is a modifiable part of function, which makes it worth identifying and addressing.
What the ACHIEVE Trial Actually Found
The Aging and Cognitive Health Evaluation in Elders, or ACHIEVE, trial provides the strongest experimental evidence to date on hearing treatment and cognitive change.
Researchers enrolled 977 adults ages 70 to 84 who had untreated mild-to-moderate hearing loss and did not have substantial cognitive impairment. Participants were randomly assigned to either a hearing intervention or a health-education program. The hearing intervention was more than receiving a device. It included hearing aids, audiologic counseling, education, and ongoing support.
After three years, the hearing intervention did not slow cognitive decline in the combined study population. That primary finding matters. It means the trial did not show that hearing treatment broadly protects cognition in every older adult with hearing loss.
The trial also included a prespecified comparison between two groups. One group consisted of generally healthier community volunteers. The other came from an ongoing heart-health study and, on average, was older and had more risk factors for cognitive decline. In that higher-risk group, the hearing intervention was associated with 48% slower cognitive decline over three years. No cognitive benefit was detected in the healthier volunteer group.
A 2025 secondary analysis reached a similar conclusion: the apparent cognitive benefit was greatest among participants with several baseline risk factors for decline. Because subgroup and secondary analyses can generate findings that need confirmation, these results should be viewed as promising rather than definitive.
Most importantly, ACHIEVE measured change on cognitive tests. It did not establish that hearing aids prevent Alzheimer’s disease or other dementias.
Communication Is a Meaningful Outcome on Its Own
Brain-health headlines can overshadow a more immediate benefit of hearing care: understanding other people.
In a secondary ACHIEVE analysis, participants who received the hearing intervention reported substantially better communication function within six months compared with the health-education group. The benefit remained through three years. Better communication can make it easier to participate in medical visits, maintain relationships, navigate work and community settings, and respond to warnings or alarms.
That is a clinically important outcome even when a person’s long-term cognitive trajectory is uncertain. A hearing aid should not be sold as a guaranteed brain-protection device. It can, however, be one part of preserving day-to-day function and connection.
What About Hearing Aids and Longevity?
A 2024 study linked federal hearing-test data from 9,885 U.S. adults to mortality records. Among the 1,863 participants with hearing loss, regular hearing-aid users had a 24% lower adjusted risk of death than people who never used hearing aids. Occasional users did not have a statistically significant advantage over never-users.
This was an observational study, not a randomized trial. Regular hearing-aid users may differ from nonusers in health behavior, resources, social support, or other ways that statistical adjustment cannot fully remove. The result therefore does not prove that hearing aids extend life. It does support further research and reinforces a broader point: hearing health may be connected to how people function and engage with care over time.
When Should You Have Your Hearing Checked?
Consider a professional hearing evaluation if you notice any of the following:
- Speech sounds muffled or conversations are hard to follow, particularly with background noise.
- Family or colleagues frequently need to repeat themselves.
- You increase the television or phone volume beyond what others find comfortable.
- Listening feels exhausting or you avoid social settings because hearing is difficult.
- You have persistent tinnitus, imbalance, or a noticeable difference between the ears.
The U.S. Preventive Services Task Force found insufficient evidence to recommend for or against routine screening in adults age 50 and older who have no symptoms. That finding does not apply to someone who notices hearing difficulty or has another clinical concern. Symptoms deserve evaluation.
Sudden hearing loss in one or both ears is different. Hearing that drops rapidly, all at once or over a few days, should be treated as a medical emergency. Seek immediate medical care, even if the ear feels clogged or you suspect earwax. Prompt diagnosis and treatment can affect the chance of recovery.
OTC or Prescription Hearing Aids?
The U.S. Food and Drug Administration permits over-the-counter hearing aids for adults age 18 and older with perceived mild-to-moderate hearing loss. They can be purchased without a prescription or required audiology visit. OTC access can be useful, but it does not make every hearing problem a self-treatment problem.
Professional evaluation is especially appropriate when hearing loss is severe, sudden, one-sided, rapidly worsening, accompanied by ear pain or drainage, or associated with significant dizziness. An audiologist can measure hearing thresholds and speech understanding, while an ear, nose, and throat clinician can assess conditions that may need medical or surgical treatment. Prescription devices can be programmed for a wider range of hearing needs.
Whichever route is chosen, fit, consistent use, realistic expectations, and follow-up matter. Hearing care may also include communication strategies, assistive listening technology, treatment of earwax or another underlying condition, and protection from hazardous noise.
Make Hearing Part of a Broader Healthy-Aging Plan
Hearing does not exist in isolation. Blood pressure, diabetes, medication effects, noise exposure, sleep, balance, mood, and cognition can overlap with hearing concerns. A thoughtful longevity plan looks for those connections without claiming that one device or intervention solves every risk.
Brainology can help evaluate neurologic, cognitive, balance, and sleep concerns that may accompany changes in hearing, and can coordinate with audiology or ear, nose, and throat care when appropriate. If conversations are getting harder to follow, bringing it up is a practical first step.
The Bottom Line
Hearing care clearly supports communication, and that benefit can last. Evidence that it slows cognitive decline is more selective: the ACHIEVE trial found no overall cognitive effect, but it identified a meaningful signal among older adults at higher risk. Observational research also links regular hearing-aid use with lower mortality, but cannot prove cause and effect.
The responsible takeaway is neither “hearing aids prevent dementia” nor “hearing loss is just part of aging.” Hearing is a treatable dimension of function, safety, and connection. That makes it an important part of healthy aging today, while research continues to define its longer-term effects.
References
- Lin FR, Pike JR, Albert MS, et al. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. The Lancet. 2023;402(10404):786-797. PubMed
- Pike JR, Huang AR, Reed NS, et al. Cognitive benefits of hearing intervention vary by risk of cognitive decline: A secondary analysis of the ACHIEVE trial. Alzheimer's & Dementia. 2025;21(5):e70156. PubMed
- Sanchez VA, Arnold ML, Garcia Morales EE, et al. Effect of hearing intervention on communicative function: A secondary analysis of the ACHIEVE randomized controlled trial. Journal of the American Geriatrics Society. 2024;72(12):3784-3799. PubMed
- Choi JS, Adams ME, Crimmins EM, Lin FR, Ailshire JA. Association between hearing aid use and mortality in adults with hearing loss in the USA: a mortality follow-up study of a cross-sectional cohort. The Lancet Healthy Longevity. 2024;5(1):e66-e75. PubMed
- National Institute on Deafness and Other Communication Disorders. Age-Related Hearing Loss (Presbycusis). NIDCD
- U.S. Food and Drug Administration. OTC Hearing Aids: What You Should Know. FDA
- U.S. Preventive Services Task Force. Hearing Loss in Older Adults: Screening. March 23, 2021. USPSTF
- National Institute on Deafness and Other Communication Disorders. Sudden Sensorineural Hearing Loss. NIDCD
Medical disclaimer: This draft is for general educational purposes and is not a substitute for individualized diagnosis or treatment. Sudden hearing loss requires immediate medical evaluation.